Abstract: Pro-infl ammatory cytokines activate the fi broblasts that reside in periodontal tissues and the polymorphonuclear leukocytes (PMNs) that are responsible for a substantial part of the destruction caused by the host response. The resident anaerobic bacteria interact with host inflammatory reactions leading to a hypoxic environment in the periodontal pocket. Expression of the transcription factor Differentiated Embryonic-Chondrocytes Expressed Gene 1 (DEC1) is regulated by hypoxia, growth factors and cytokines. To reveal the biological relevance of hypoxia in periodontal infl ammation, we examined the role of DEC1 in the responses of human periodontal ligament cells to treatment with lipopolysaccharide (LPS), P. gingivalis and/or hypoxia. We found significantly increased levels of DEC1 after hypoxic or inflammatory stimulation of periodontal ligament cells. To further characterize the role of DEC1 in that process, inhibition by DEC1 siRNA was used in the experiments. The results demonstrated that treatment with the DEC1 siRNA inhibited the effects of LPS and hypoxia. Immunohistochemistry performed on an experimental animal model of periodontitis revealed an increase of PMN immunoreactivity, which validated the importance of the in vitro results. Treatment of DEC1-knockout mice with P. gingivalis decreased the production of PMN in periodontal ligament cells. These results demonstrate that DEC1 interference in the pathophysiological process of hypoxia has fundamental relevance for periodontal defenses.
Introduction
Hypoxia and inflammation share an interdependent relationship 1) .
Recent studies have implicated hypoxia-elicited inflammation, i.e. infl ammation that occurs during hypoxic conditions, in the outcomes of a wide array of human diseases 2) . On the one hand, infl ammatory disease states are frequently characterized by tissue hypoxia and the stabilization of hypoxia-dependent transcription factors, such as hypoxia-inducible factor (HIF) 3) . For example, intestinal inflammation, such as occurs during infl ammatory bowel disease, is characterized by the occurrence of severe hypoxia of the mucosal surface and the concomitant stabilization of HIF 4, 5) . The stabilization of HIF1A during intestinal infl ammation is caused by alterations in metabolic supply and demand ratios, particularly for oxygen, that lead to "inflammatory hypoxia" 6) . Similarly, lung inflammation occurs during acute lung injury and is associated with metabolic alterations leading to the stabilization of HIF1A 7) .
Expression of the hypoxia responsive gene Diff erentiated EmbryonicChondrocytes Expressed Gene 1 (DEC1) is highly elevated in response to various environmental stimuli [8] [9] [10] . In rats that undergo seizure induction by kainic acid, levels of DEC1 mRNA are sharply increased within 1 h in the brain 9) . In cultured human cells, DEC1 is markedly induced in response to hypoxia 11) . Co-transfection experiments with promoter reporters have identifi ed functional hypoxia response elements in the DEC1 gene. Those elements show a high affi nity toward hypoxiainducible factor-1α (HIF-1α), providing a molecular explanation for the regulatory phenomenon of DEC1 during the hypoxia response 11) . Hypoxia and infl ammation are intertwined at the molecular, cellular and clinical levels. Oxygen-sensing mechanisms and hypoxia signaling are potential therapeutic targets for the treatment of inflammatory diseases. Several studies have investigated the relationship between hypoxia and infl ammation and have shown that hypoxia, by itself or in combination with lipopolysaccharide (LPS), can increase the release of inflammatory cytokines in various cell types [12] [13] [14] [15] . Furthermore, hypoxic conditions at infl ammatory sites can enhance the susceptibility to infection and inflammatory signals by up-regulating inflammatory cytokines 16) . Among those inflammatory cytokines, interleukin-1β (IL-1β) has been shown to be crucial for systemic and local inflammatory conditions and is also an initiator and progressive inducer of connective tissue destruction 17) . We previously demonstrated that the neutralization of IL-1β results in the reduction of infl ammation severity 18) . Periodontal disease occurs as a result of mixed microbial infections within which specific groups of pathogenic bacteria coexist [19] [20] [21] . The potential roles of modifiable and nonmodifiable risk factors associated with periodontal disease have been established. In this context, the very potent bacteria P. gingivalis may be of particular importance as a possible stimulator of DEC1 in the gingiva under inflammatory and/ or hypoxic conditions. DEC1 can be induced by HIF-1α and is crucial for adaptation to hypoxia 11) . Taking into account the results obtained for increased mononuclear cell infiltrates in tissues treated with LPS compared to non-treated tissues, our previous data supported the idea of the participation of infl ammation and hypoxia in the development of periodontal disease, which nonetheless remains a multi-factorial process.
The cell composition and the existence of infl ammatory cells refl ect its chronic nature, which may result in a long-term local stimulation process that leads to periodontitis. Despite intensive studies, our understanding of the regulation of DEC1 and periodontal infl ammation is still limited. On the basis of the above considerations, in the present study we set out to investigate the regulation of immune responses by hypoxia-induced signaling, to outline the molecular aspects of the cross-talk between hypoxia and infl ammation, and to illustrate the link between hypoxia and infl ammation in periodontal disease.
Materials and Methods

Animals
The animals used in this study have been described in our previous report. Briefly, DEC1
−/− (DEC1-KO) mice were generated by the inGenious Targeting Laboratory, Inc. (Stony Brook, NY, USA). The 4.7-kb BamHI-BssSI genomic fragment of DEC1, which contains the entire coding region in exons 1 to 5, was replaced with a Neo cassette. The resulting chimeric mice were back-crossed to a C57BL/6J background for three generations. Male DEC1-KO mice (n = 12) and their wild-type (WT) littermates (n = 12) that were 5 weeks of age were individually housed under specifi c pathogen-free conditions. All procedures were performed in compliance with the standard principles and guidelines for the care and use of laboratory animals at Kanagawa Dental University.
Cell culture
Human periodontal ligament cells (PDL) were obtained from Professor T. Takata (Hiroshima University, Japan) and were cultured in Dulbecco's modified Eagles medium (DMEM; Wako Pure Chemical Industries, Osaka, Japan) containing 10% fetal bovine serum (FBS; Biowest, Riverside, MO, USA). The cells were seeded in 60-mm plastic tissue culture dishes and were incubated in 5% CO 2 at 37°C. When the cells reached sub-confluence, they were harvested and sub-cultured. Cells at the fourth passage were used in these experiments. Human gingival fi broblast cells HGF-1(CRL-2014, ATCC, Manassas, VA, USA) were also used in some experiments. LPS from P. gingivalis and human recombinant IL-1β were added to the cultures for 24 h to evaluate the effects of treatment with bacteria and cytokine. The concentrations of P. gingivalis LPS 22) and IL-1β used were adopted from our previous studies 18) .
Short interference RNA (siRNA)
The siRNAs used were described in our previous report23). Briefly, siRNAs against DEC1 were synthesized by Qiagen (Hilden, Germany). The sequences for the sense and antisense DEC1 siRNAs were 5′-r (CCAAAGUGAUGGACUUCAA) d (TT)-3′ and 5′-r (UUGAAGUCCAUCACUUUGG) d (GA)-3′, respectively. We also used another siRNA against DEC1 (DEC1 siRNA-2). The sequences for the sense and antisense DEC1 siRNA-2 were siRNAs were transfected into those cells using the lipofectamine RNA iMAX reagent (Thermo Fisher Scientifi c, Waltham, MA, USA), and the cells were incubated for 48 h and then treated with LPS and/or hypoxia for various analyses.
RNA extraction, RT-PCR and Quantitative Real Time-PCR (QRT-PCR)
Total RNA was extracted from PDL using an RNeasy Mini Kit (Qiagen, Tokyo, Japan), as described previously 23) . A TURBO DNAfree™ Kit (Applied Biosystems, Foster City, CA, USA) was used to remove contaminating DNA from the RNA preparations. First-strand cDNAs were synthesized from 1 μg total RNA using High Capacity RNA-to-cDNA Master Mix (Applied Biosystems), according to the manufacturers' protocol. For RT-PCR, the reaction mixture (20 μl) contained 1 μl of diluted cDNA sample and 10 pmol of each pair of oligonucleotide primers. PCR conditions included an initial denaturation at 95°C for 10 min, followed by a 30-cycle amplifi cation consisting of denaturation at 94°C for 15 s, annealing at 55°C for 30 s and extension at 72°C for 30 s. The primers used in RT-PCR analysis are as follows: DEC1 (Forward 5'AGAACACTCGGGACCTGAAG3', Reverse 5' CCCTTCTCCGATTCTCCTCC3'). All primer pairs were checked for primer-dimer formation using the three-step protocol described above without the addition of the RNA template. As an additional control for each primer pair and each RNA sample, the cDNA synthesis reaction was carried out in the absence of reverse transcriptase in order to identify whether residual genomic DNA contaminated the RNA samples. The relative expression levels of target mRNAs, compared to the level of β-actin RNA, were analyzed by real time PCR with the corresponding TaqMan MGB probes (Hs01041212_m1 for DEC1, and Hs01060665_ g1 for β-actin) using QuantStudio 6 Real Time PCR System (Applied Biosystems). The thermal cycling conditions used were according to the TaqMan Fast Universal PCR protocol.
Western blot analysis PDL cells were lysed in RIPA lysis buff er (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Protein concentrations were determined using a BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL, USA). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were calibrated with molecular weight markers (Bio-Rad, Hercules, CA, USA). Anti-DEC1 (1:500; obtained from Professor Yukio Kato, Hiroshima University), Anti-Notch 1 (1:1000; Abcam, Cambridge, MA, USA), and anti-β-actin (1:1000; Cell Signaling Technology, Danvers, MA, USA) rabbit polyclonal antibodies were used. A horseradish peroxidase-conjugated anti-rabbit secondary antibody (Cell Signaling Technology) was used at a dilution of 1:2000. Bound antibodies were visualized by chemiluminescence using the ECL Plus Western Blotting Detection System (GE Healthcare, Tokyo, Japan), and images were analyzed using a Luminescent ImageQuant LAS 4000 Mini (GE Healthcare).
Preparation of bacteria
P. gingivalis ATCC 33277 was grown in brain heart infusion broth supplemented with 5 mg/ml yeast extract, 5 μg/ml hemin and 0.2 μg/ml vitamin K1, as described previously 24) . Bacterial cells were grown under anaerobic conditions (85% N 2 , 10% H 2 and 5% CO 2 ) at 37°C for 24 h. LPS from P. gingivalis ATCC 33277 was obtained from P. gingivalis according to the manufacturer's instructions (iNtRON Biotechnology, Kyungki-Do, Korea).
Experimental periodontitis
An established method of experimental periodontitis has been previously reported 24) . Briefl y, 5-week-old male C57BL/6 (CLEA Japan, Inc., Tokyo, Japan) and DEC1-KO mice were given sulfamethoxazole (1 mg/ml) and trimethoprim (200 μg/ml) in their drinking water for 4 days to reduce any existing oral microorganisms, followed by a 3-day antibiotic-free period before starting the oral treatment with P. gingivalis. Mice had free access to laboratory chow and tap water. They were randomly divided into three experimental groups of 6 mice each [Group A: treated with 5% carboxymethylcellulose (CMC) (control; C57BL/6 group); Group B: treated with P. gingivalis ATCC 33277 (C57BL/6 + P. g. group); Group C: treated with P. gingivalis ATCC 33277 (DEC1-KO + P. g. group)]. Each mouse treated with P. gingivalis received 0.5 ml (1.0 × 10 8 cells/ml) of the bacterial suspension in 5% CMC by oral gavage at 8, 10, 12, 14 and 16 days. All mice were sacrificed by CO 2 inhalation 30 days after the last gavage.
Micro-computed tomography
The left side of the upper jaw of each mouse was used as a dry specimen for measuring alveolar bone loss. Three-dimensional (3D) imaging data for each mandibular bone were collected using microcomputed tomography (micro-CT) (MCT-CB100MF; Hitachi medico, Tokyo, Japan) under the following exposure conditions: tube voltage, 70 kV; tube current, 100 μA; voxel size, 17 × 17 × 17 μm.
Immunohistochemistry
Formalin-fixed, paraffin-embedded gingival tissue sections were immunostained for PMNs with a CSA II System (Dako, Carpinteria, CA, USA), in accordance with the manufacturer's instructions. Sections were initially immersed in Target Human periodontal ligament cells were transfected with a control siRNA or with an siRNA against DEC1, incubated for 48 h, treated with or without LPS and/or hypoxia as noted, and then incubated for 24 h. (A) Total RNA was then prepared and subjected to RT-PCR and realtime PCR analyses of DEC1 and β-actin; each value represents the mean ± SD (bars) of DEC1 mRNA levels relative to β-actin determined in three independent experiments. *P < 0.05, compared with the control cells (scrambled siRNA). (B) Cell lysates were prepared and subjected to Western blot analysis for DEC1, Notch1 and β-actin; the experiments were repeated three times. * * * was used as a primary antibody and was incubated overnight at 4°C. A secondary antibody conjugated to peroxidase (Nichirei Biosciences, Tokyo, Japan) was then incubated at room temperature for 30 min. After rinsing with PBS, all specimens were color developed with a 3,3′-diaminobenzidine tetrahydrochloride (DAB) chromogen kit (Dako), counterstained with hematoxylin, and examined by light microscopy. The immunostaining of all specimens was performed simultaneously to ensure the same antibody reaction and DAB exposure conditions.
Statistical analysis
Statistical analyses were done by one-way ANOVA and Dunnett's Test. A P-value of less than 0.05 is considered statistically signifi cant.
Results
LPS stimulates the expression of DEC1 mRNA in human PDL
In order to confi rm the expression levels of DEC1 in LPS-induced human PDL, DEC1 mRNA expression levels were evaluated using RT-PCR and quantitative real-time PCR. Treatment of human periodontal cells with P. gingivalis LPS (500 μM and 1000 μM) increased the expression level of DEC1 mRNA (Fig. 1A) . DEC1 mRNA expression was also up-regulated in hypoxic and in IL-1β-treated cells (Fig. 1B) .
DEC1 is necessary for periodontal infl ammation in vitro
To investigate the detailed mechanism of periodontal infl ammation induced by DEC1, we analyzed the eff ects of knocking down DEC1 in PDL using an siRNA targeting DEC1. DEC1 knockdown by siRNAs markedly reduced the expression of DEC1 mRNA with LPS treatment. siRNA knockdown of DEC1 significantly decreased the expression levels of LPS and hypoxia-induced DEC1 mRNA ( Fig. 2A ), DEC1 and Notch1 protein (Fig. 2B ).
DEC1 defi ciency protects mice from P. gingivalis-induced infl ammation WT and DEC1-KO mice were exposed to 5 intraoral treatments with P. gingivalis over a 10-day period. Notably, DEC1-KO mice were partially protected from periodontal inflammation compared with WT controls. Micro-CT analysis demonstrated that P. gingivalis caused a decrease in bone area compared with the vehicle-treated control group (Fig. 3) .
Increased expression of PMN in a P. gingivalis-challenged experimental periodontitis animal model
To investigate the effects of DEC1 in the P. gingivalis-challenged experimental periodontitis model, mice were challenged with P. gingivalis and maintained for 4 weeks. Immunohistochemical analysis showed an increased number of PMNs in the P. gingivalis-challenged mice, while the number of PMNs was decreased in DEC1-KO P. gingivalis-treated tissues (Fig. 4A) . The number of PMNs was increased about 3 -fold in P. gingivalis-challenged mice (P < 0.05) (Fig. 4B) . DEC1-KO mice had a signifi cantly reduced infi ltration of PMNs compared to the P. gingivalis C57BL/6 control C57BL/6 P. g. DEC1-KO P. g. 
Micro-CT
PMN group (P < 0.05).
Discussion
The broad spectrum of cytokines that aff ects the transcription of DEC1 implies an important role for DEC1 in functionally pleiotropic processes of cell growth, differentiation, apoptosis and immune responses. The essential importance of the present findings is that DEC1, a core component of the Clock system, inhibits bone resorption through its expression in PDL by modulating the PMN-dependent regulation. It has been previously demonstrated that a high bone mass with elevated boneformation parameters is observed in mice lacking Per or Cry, the clock genes, which are negative regulators of gene transcription 25) . Moreover, we have previously shown that various cytokines converge upon Akt to participate in DEC1 regulation and that DEC1 activation may occur in response to diverse cellular stimuli 18) .
We now report the novel finding that DEC1 gene expression is regulated by neutrophil signaling. It therefore seems that neutrophils play a central role in periodontal infl ammation. We conclude that neutrophils can also be considered as physiological sensors in immunological changes to the molecular clock and thereby coordinate the special needs to specifi c time windows.
IL-1β displays a circadian rhythm in the circulation and its expression is rhythmic in fi broblasts 26, 27) . It can be concluded that DEC1 is aberrantly expressed in periodontal tissues, that it is induced by LPS and not only affects the expression of genes belonging to the molecular clock but also significantly impacts the expression of PMN as well as other infl ammatory genes.
Endogenous expression of DEC1 is significantly increased by treatment with IL-2, IL-6, IL-12, IL-15, TNF-α and IFN-β, while the eff ects of IL-1β, IL-4, IL-7, IL-18 and IL-21 are less pronounced, after 3 h of stimulation in human NK-92 natural killer cells 14) . We also performed a preliminary screening of LPS, IL-1β and hypoxia-treated human PDL for 24 h and found increased expression levels of DEC1 mRNA in the analyzed samples.
Hypoxia is a normal condition that can be detected in infl ammatory areas 28, 29) . Prolonged hypoxic conditions can affect the expression of many cytokines, including IL-1β, IL-6 and TNF-α 13, 14, 30, 31) . The present study demonstrates the influence of low oxygen levels in combination with LPS to regulate the expression of infl ammatory cytokines in human PDL. Our results indicate that hypoxia and LPS synergistically induce the expression of DEC1 mRNA. Moreover, the results from experiments using siDEC1 indicate that DEC1 is involved in LPS-stimulated periodontal infl ammation. Thus, we suggest that the mechanism to inhibit the LPS-induced production of inflammatory cytokines is related to DEC1. The explanation for these observations may be as follows: hypoxia augments LPS-stimulated DEC1 mRNA expression in human PDL as a direct eff ect of DEC1. Our results demonstrate that the LPS-stimulated DEC1 expression in human PDL and hypoxia enhances the virulence of LPS to induce DEC1 expression using a DEC1-dependent pathway.
